Looking To Learn From Past Failures, Galapagos Pivots To Immunology And CAR-T

200 Jobs Shed And Pipeline Cut Back

 
• By Andrew McConaghie
  
Cocoon
Galapagos has acquired Cellpoint and its point-of-care manufactured CAR-T technology called 'Cocoon'. • Source: Galpagos
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip